The global biotechnology market is driven by modernization, streamlined approval processes, and increased focus on personalized medicine. The pandemic has positively impacted the market, fostering advancements in drug development and vaccine manufacturing.
Therefore, investors could consider investing in top biotech stocks Merck KGaA (MKKGY), Entrada Therapeutics, Inc. (TRDA), and Gilead Sciences, Inc. (GILD). These companies boast robust profit margins and are quite undervalued than their industry peers.
